Treatment-associated stroke in patients undergoing endovascular therapy in the ARUBA trial
Stroke Oct 17, 2021
Burks JD, Luther EM, Govindarajan V, et al. - In patients undergoing endovascular intervention for unruptured brain arteriovenous malformation, the risk of perioperative stroke is reliant on Spetzler-Martin grade and posterior-circulation arterial supply. Stroke risk may also be influenced by differences in regional treatment paradigms.
No previous analysis focused on risk factors for perioperative stroke in patients undergoing endovascular therapy in the ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations) Trial.
This study involved 64 ARUBA patients; 159 interventions were conducted, and 26 (16%) procedures led to stroke within 48 hours of treatment.
In those who received endovascular intervention, increased perioperative stroke risk was found in relation to posterior cerebral artery supply (adjusted odds ratio, 4.42) and Spetzler-Martin grades 2 and 3 arteriovenous malformation (adjusted odds ratio, 7.76 and 9.64, respectively).
A significantly lower stroke risk was observed in patients treated in the United States or Germany vs those treated in other countries (adjusted odds ratio, 0.18).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries